Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$3.33M Sell
53,752
-742
-1% -$45.2K 0.95% 30
2016
Q1
$3.11M Sell
54,494
-1,412
-3% -$78.7K 0.91% 33
2015
Q4
$3.31M Sell
55,906
-6,649
-11% -$383K 0.92% 33
2015
Q3
$3.4M Sell
62,555
-759
-1% -$49.4K 0.89% 33
2015
Q2
$4.25M Sell
63,314
-2,546
-4% -$166K 0.95% 31
2015
Q1
$3.85M Sell
65,860
-4,488
-6% -$271K 0.85% 33
2014
Q4
$4.6M Sell
70,348
-5,613
-7% -$354K 0.98% 29
2014
Q3
$4.39M Sell
75,961
-5,011
-6% -$278K 0.92% 31
2014
Q2
$4.57M Sell
80,972
-4,182
-5% -$219K 0.95% 31
2014
Q1
$4.38M Sell
85,154
-4,326
-5% -$219K 0.87% 32
2013
Q4
$4.72M Sell
89,480
-7,437
-8% -$366K 0.91% 32
2013
Q3
$4.33M Sell
96,917
-18,020
-16% -$799K 0.93% 29
2013
Q2
$4.75M Buy
+114,937
New +$5.03M 1% 27

Other funds holding ABBV

First Niagara Bank's ABBV Position: Q2 2016 in Review

First Niagara Bank reduced its AbbVie (ABBV) stake by 1.4% in Q2 2016, selling an estimated $45.2K and leaving 53,752 shares worth $3.33M. The position accounts for 0.95% of the portfolio, ranked #30.

First Niagara Bank first reported a position in ABBV in Q2 2013 and has held it in 13 quarters since. The position peaked at $4.75M in Q2 2013. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • First Niagara Bank held 53,752 shares of AbbVie worth $3.33M as of Q2 2016.
  • First Niagara Bank sold 742 AbbVie shares in Q2 2016, an estimated $45.2K.
  • AbbVie made up 0.95% of First Niagara Bank's portfolio in Q2 2016, its #30 holding.
  • First Niagara Bank first reported a position in AbbVie in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's AbbVie position peaked at $4.75M in Q2 2013.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.